After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Beam Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Beam Therapeutics Inc is $2.22B. A total of 1.31 million shares were traded on the day, compared to an average of 1.15M shares.
In the most recent transaction, Bellon Christine sold 1,241 shares of BEAM for 24.68 per share on Jan 02 ’25. After the transaction, the Chief Legal Officer now owns 102,968 company shares. In a previous transaction on Jan 02 ’25, Cavanagh Bethany J sold 1,117 shares at 24.68 per share. BEAM shares that SVP, Finance and Treasurer owns now total 43,814.
Among the insiders who bought shares, BETHANY J. CAVANAGH acquired of 9,500 shares on Dec 31 ’24 at a per-share price of $25.27. In another insider transaction, CHRISTINE BELLON bought 4,167 shares at $25.27 per share on Dec 31 ’24.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BEAM has a high of $49.50 and a low of $20.84.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BEAM’s latest balance sheet shows that the firm has $965.65M in Cash & Short Term Investments as of fiscal 2021. There were $142.35M in debt and $213.44M in liabilities at the time. Its Book Value Per Share was $9.58, while its Total Shareholder’s Equity was $826.74M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BEAM is Buy with a score of 4.18.
